RE:RE:RE:RE:Who the **** is selling at these prices?skier59 wrote: Johnny BJ is still being the constant dichead. Maybe the guy doesn't have any available cash.
Phase 2 will start in Canada, so you can stop saying a Phase 2 will never start, fluck you and your attitude that USA is the be all of everything and nothing else matters. Seems you have that Canadian Shithawk on your side with all the other Trumpsters and molesters. Just Deny and Lie, it's the American way !
bionicjoe wrote: Eoganacht wrote: Dr. Mandel has options for 500,000 shares
Mthompson123 wrote: People just tired of waiting I guess. Grass always looks greener....
Crazy to give up at this stage of the game.
Insider buying (including 3 Board members) is definitely reassuring.
Why Arkady doesn't bite is kind of strange, but maybe he's in-line for some free warrants as CEO so he's covered for upside without having to reach into his pockets.
I hope everyone who sells at these prices lives to forever regret it :)
Mandel received those free options when he became interim CEO. He also holds the job of Chief Science Officer whose duties have been to oversee all of TLT's pre-clinical and clinical work. In that capacity he is privy to all sorts of insider candid information not available to the market. How then does it look when he doesn't personally own any shares in the company but expects others to risk their money? I can assure this board that fact is not lost on members of the capital markets. RW and his CFO wife are almost single handily keeping this company afloat for the last year. One can argue it's to be expected since they are the founders after all but their contribution is only a stop gap measure. This company still has to find the money to pay for the phase 2 study. Just don't ask the CEO to break open the wallet because he doesn't believe in risking his personal money but he's ok with you doing it.
Skier59, do you think he has a packed suitcase by his bedside in case he has to make a quick getaway? It sure doesn't look like he wants to establish roots in TLT. I guess he figures if TLT goes titts up it's no skin off his nose. There's always a job out there for someone of his experience. Can't be too careful. The bottom line is that it's a definite turn off when the man in charge of the cancer department for this company doesn't own any shares while telling the market how amazing the science is.